Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy

Andrew Maltez Thomas; Marine Fidelle; Bertrand Routy; Guido Guido Kroemer; Jennifer A. Wargo; Nicola Segata; Laurence Zitvogel

doi:10.1038/s41571-023-00785-8

Related publications

Article2016

Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome

Jonathan M. Pitt, Marie Vétizou, Nadine Waldschmitt, Guido Guido Kroemer, Mathias Chamaillard, Ivo G. Boneca, Laurence Zitvogel

Article2025

144P Subclinical cholestasis as a hallmark of gut dysbiosis causing resistance to cancer immunotherapy

A-L. Mallard de la Varende, H. Guillaume dit Taunière, Sylvère Durand, Thomas Simon, Daniel Suissa, F-X. Danlos, Aurélien Marabelle, Caroline Truntzer, A. Fouquier, C. Alves Costa Silva, Federica Marmorino, Chiara Cremolini, Paula A. Bousquet, Sebastian Meltzer, Anne Hansen Ree, François Ghiringhelli, Guido Guido Kroemer, Lisa Derosa, L. Zitvogel, Marine Fidelle

Article2011

Hallmarks of Cancer: The Next Generation

Douglas Hanahan, Robert A. Weinberg

Article2018

The intimate relationship between gut microbiota and cancer immunotherapy

Arielle Elkrief, Lisa Derosa, Laurence Zitvogel, Guido Guido Kroemer, Bertrand Routy

Article2014

Mxene As A Novel Material For Next Generation Desalination Membranes

Chang Ren, Mohamed Alhabeb, Zheng Ling, Kelsey B. Hatzell, Müge Açık, Khaled A. Mahmoud, Yury Gogotsi